Dr. Reddy's Laboratories
230 hedge funds and large institutions have $1.73B invested in Dr. Reddy's Laboratories in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 92 increasing their positions, 73 reducing their positions, and 20 closing their positions.
161% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $733K
45% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 20
26% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 73
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
3% more funds holding
Funds holding: 223 → 230 (+7)
2% more capital invested
Capital invested by funds: $1.7B → $1.73B (+$37.4M)
2.23% less ownership
Funds ownership: 73.05% → 70.81% (-2.2%)
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$60.1M |
| 2 |
Morgan Stanley
New York
|
-$55.5M |
| 3 |
Goldman Sachs
New York
|
-$20.3M |
| 4 |
Lazard Asset Management
New York
|
-$13.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.55M |
RDY Hedge Fund Activity: Q1 2024 in Review
230 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2024, worth a combined $1.73B — up 2.2% from $1.7B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new RDY positions and 20 closed out — a net gain of 9 holders — while 92 added to existing stakes and 73 trimmed.
The largest buyer was Bank of America, adding an estimated $24M. The largest seller was BlackRock, cutting an estimated $60.1M.
- 230 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2024, up from 223 in Q4 2023.
- Funds reported $1.73B of Dr. Reddy's Laboratories stock for Q1 2024, up 2.2% quarter-over-quarter.
- 29 funds opened new Dr. Reddy's Laboratories positions in Q1 2024 and 20 closed out, a net change of +9 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2024 was Bank of America, an estimated $24M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2024 was BlackRock, an estimated $60.1M sold.
Based on aggregated 13F filings for Q1 2024.